Molecular Diagnostics. Castle Medical LLC.

Size: px
Start display at page:

Download "Molecular Diagnostics. Castle Medical LLC."

Transcription

1 Molecular Diagnostics Castle Medical LLC.

2 What is DNA testing? Pharmacogenomics is a scientific disciple that deals with the influence of patient s genotype on drug response. Objective: to deliver the right drug for the right patient at the right time. Pharmacogenomics is a tool that enables a switch from the one size fits all approach to a personalized therapy approach.

3 What is DNA testing? MOTHER FATHER This test is based on DNA genotyping NOT Sequencing Two copies AKA alleles of each gene. Both normal alleles Wild type (normal). One normal one mutated allele Heterozygous. Both mutated alleles Homozygous.

4 Benefits of DNA testing? Patients Physicians Health insurance companies Improve therapeutic effects Minimize unpleasant side effects Results are interesting and last a lifetime Improve safety and efficacy of the therapy Improve patients compliance (fewer side effects) Improve patients confidence in therapy Permanent takeaway information improves satisfaction Right drug to right patient minimize monetary loss. Example: Plavix Cutting-edge tech and takeaway information attracts clients

5 General introduction 1. CORE DME Panel 2. Warfarin Panel 3. Chemo Panel 4. MTHFR Test * One tube is not sufficient to get enough DNA to perform multiple tests. Please provide one tube for each test.

6 Collection technique Improper collection leads to delays and rejections. Make sure to connect with people responsible for DNA collections! Follow Castle s written instructions over those on the packaging Nothing in the mouth for 30 minutes beforehand Soak up saliva from between cheek and gum avoid teeth 30+ seconds on each side of the mouth total of at least 1 minute of collection

7 CORE DME panel (extended) CYP2D6 CYP2C9 CYP2C19 CYP3A4 CYP3A5 Common drug metabolizing enzymes tested in the old CORE DME panel CYP2B6 COMT OPRM1 SLCO1B1 New genes added to the panel

8 CORE DME panel (extended) CYP enzymes CYP (normal) Inactive products Remove from the body Active drugs Active drugs CYP (defective) Inactive products Drugs accumulate in the body Adverse effects ***To view the list of drugs affected by CYPs please go to

9 CORE DME panel (extended) CYP enzymes CYP (normal) Active products Therapeutic effect Prodrugs (inactive) CYP (defective) Active products Therapeutic failure Prodrugs (inactive) ***To view the list of drugs affected by CYPs please go to

10 CORE DME panel (extended) SLCO1B1 SLCO1B1 (normal) Drugs Inactive products Liver SLCO1B1 (defective) Drugs accumulate in the blood Liver Drugs affected: Cholesterol lowering drugs Statins. Eg. Simvastatin.

11 CORE DME panel (extended) OPRM1 OPRM1 (normal) Normal pain relief Opioid drugs OPRM1 (defective) Less pain relief Opioid drugs

12 CORE DME panel (extended) COMT COMT (normal) maintains their balance in the brain Neurotransmitters i.e Dopamine, adrenaline, serotonin Regulate Behavior, emotions, wisdom, judgment COMT (defective) leads to abnormal levels of neurotransmitters Neurotransmitters i.e Dopamine, adrenaline, serotonin Psychiatric disorders

13 Vocabulary Enzyme A protein that helps carry out a chemical reaction. Genotype What we know about a person s DNA. Helps us make predictions about their health. Phenotype The way a person actually is. Phenotypes on our reports are predictions based on patients genetics.

14 Core DME Sample Report

15 Core DME: Recommendations

16 Core DME: Inducers and Inhibitors Some drugs and plants can speed up or slow down the action of drug metabolizing enzymes. They can do this by sticking to enzymes directly or by causing cells to make more or less of an enzyme. This is one of the causes of drug interactions like taking statins with grapefruit juice.

17 Warfarin panel Warfarin is an anticoagulant used in thromboembolic disease. Too much warfarin. Excessive bleeding. Possible death Good target level of warfarin Too little warfarin. Clot formation. Possible death *Due to different genetic makeup every individual has different capacity to respond towards warfarin

18 Warfarin panel VKORC1 CYP2C9 GGCX CYP4F2 CACNA1C Regulate warfarin response Castle s warfarin panel results Add in Right dose of warfarin based on patient s genetic makeup

19 Warfarin panel

20 Warfarin panel Warfarin panel

21 MTHFR test What is MTHFR? This enzyme plays a critical role in vitamin-b12 and folate metabolism. What are consequences of Genetic defect in MTHFR gene? Less efficient enzyme activity that can lead to elevated homocysteine (a potentially toxic amino acid) levels. What are consequences of high homocysteine levels? Increase risk of developing cardiovascular disorders, psychiatric disorders, cancer, osteoporosis and pregnancy complications.

22 MTHFR test MTHFR DNA test Ora Collect Buccal swab AND OR Homocysteine quantification Urine sample Blood sample *Before collecting urine/blood samples, fasting for at least 12 hours is recommended.

23 MTHFR test Target clinics Cardiology clinics- This test is specially relevant for people who have a personal or family history of premature cardiovascular disease or thrombosis. It may also be ordered when a close relative has MTHFR gene mutations. Maternity hospitals- Prospective mothers with a history of miscarriages are also advised to go for this test.

24 MTHFR test..

25 MTHFR test..

26 In the Future Expanded Core panel is validated and will replace the old panel in early September Sequencer is running but not validated for clinical tests will test BRCA1, BRCA2 and PALB2 Tests on the new Core panel came from your and clinics suggestions. Keep them coming!

27 Thanks for listening! Any questions?

YOUR FIRST CHOICE FOR IN-OFFICE GENETIC TESTING

YOUR FIRST CHOICE FOR IN-OFFICE GENETIC TESTING YOUR FIRST CHOICE FOR IN-OFFICE GENETIC TESTING THE NEW STANDARD OF CARE WHY GENETIC TESTING? Genetic testing makes it possible to know a priori how your patients will metabolize a specific drug. It is

More information

The future is. Personalized Medicine.

The future is. Personalized Medicine. The future is Personalized Medicine. What is Pharmacogenomics (PGx)? Pharmacogenomics and Personalized Medicine Patient Adherence Many commonly prescribed medications used to treat everyday ailments can

More information

The PREDICT Program at Vanderbilt : Four Drug Gene Interactions and Counting

The PREDICT Program at Vanderbilt : Four Drug Gene Interactions and Counting The PREDICT Program at Vanderbilt : Four Drug Gene Interactions and Counting Michael Laposata, MD, PhD Fody Professor of Pathology Professor of Medicine Pathologist in Chief Vanderbilt University Hospital

More information

Introduction to Pharmacogenetics Competency

Introduction to Pharmacogenetics Competency Introduction to Pharmacogenetics Competency Updated on 6/2015 Pre-test Question # 1 Pharmacogenetics is the study of how genetic variations affect drug response a) True b) False Pre-test Question # 2 Pharmacogenetic

More information

Introduction to Pharmacogenomics in Pharmacy Practice

Introduction to Pharmacogenomics in Pharmacy Practice Pharmacy Technician Education for Association Members By: Brad Tice PharmD, MBA, FAPhA Brad Tice received his bachelor of science in pharmacy from the University of Kansas in 1994 and his doctor of pharmacy

More information

Cytochrome P450 Genotype Panel

Cytochrome P450 Genotype Panel DOB: Age: Gender: Visit Number (FIN): Patient Results Client: Physician: ARUP Test Code: 2013098 Collection Date: 11/29/2016 Received in lab: 11/30/2016 Completion Date: 12/07/2016 Gene Genotype Phenotype

More information

Clinical Applications in Pharmacogenomics/Genomic Medicine. Post-Course Survey

Clinical Applications in Pharmacogenomics/Genomic Medicine. Post-Course Survey Clinical Applications in Pharmacogenomics/Genomic Medicine Post-Course Survey Note: Students will be asked questions specific to the course in which they are enrolled. This is denoted throughout by use

More information

PERSONALIZED MEDICINE & ADVANCES IN DRUG METABOLISM

PERSONALIZED MEDICINE & ADVANCES IN DRUG METABOLISM PERSONALIZED MEDICINE & ADVANCES IN DRUG METABOLISM BY ANDREW BRADFORD, PHD, CLINICAL TESTING LABORATORIES, BILL MASSEY, PHD, MYGENESRX, AND R. JAMES BENTLEY, GENERAL GENETICS CORPORATION 48 datia focus

More information

CE Activity Announcement

CE Activity Announcement Pharmacogenomics Certificate Program ACPE Activity Number(s): 0204-0000-18-743-H04-P thru to 0204-0000-18-745-H04-P 0204-0000-18-746-H01-P and 0204-0000-18-747-H01-P 0204-0000-18-748-H04-P thru to 0204-0000-18-750-H04-P

More information

Introduction to Genetics and Pharmacogenomics

Introduction to Genetics and Pharmacogenomics Introduction to Genetics and Pharmacogenomics Ching-Lung Cheung, PhD Assistant Professor, Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, HKU Survey on pharmacogenomic knowledge Survey

More information

geneombio Technologies

geneombio Technologies PHARMACOGENOMICS SERVICES geneombio Technologies PHARMACOGENOMICS S A] CANCER GENETICS Sr. No 6 8 9 0 Test Name METHOTREXATE TOXICITY (MTHFR, RFC) AZATHIOPRINE TOXICITY (TPMT) OXALIPLATIN RESPONSE PREDICTION

More information

Personalized Human Genome Sequencing

Personalized Human Genome Sequencing Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome

More information

RESPONSE TO RFP - Title Page

RESPONSE TO RFP - Title Page University of Pennsylvania RESPONSE TO RFP - Title Page Request for Proposal (RFP) Number: 002 Issue Date: July 16, 2008 Proposal Due Date: August 18 2008 Title of RFP: Central Laboratory for a Randomized

More information

Introduction to Pharmacogenomics

Introduction to Pharmacogenomics Introduction to Pharmacogenomics Ching-Lung Cheung, PhD Assistant Professor, Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, HKU Overview of the lecture Overview of the lecture Introduction

More information

Personalized Medicine: Will There be a Right Time to Implement?

Personalized Medicine: Will There be a Right Time to Implement? Pharmacogenomics based personalized medicine: Are the standards of evidence requirements different from standards for Clinical-Based Personalized Medicine? Devender S. Dhanda MS MBA, Greg F. Guzauskas

More information

PHARMACOLOGY Vol. I - Pharmacogenomics and Pharmacogenetics - Andrew A Somogyi and Janet K Coller PHARMACOGENOMICS AND PHARMACOGENETICS

PHARMACOLOGY Vol. I - Pharmacogenomics and Pharmacogenetics - Andrew A Somogyi and Janet K Coller PHARMACOGENOMICS AND PHARMACOGENETICS PHARMACOGENOMICS AND PHARMACOGENETICS Andrew A Somogyi and Janet K Coller Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia Keywords:

More information

Activity 4.3.2: Hypercholesterolemia

Activity 4.3.2: Hypercholesterolemia Activity 4.3.2: Hypercholesterolemia Introduction In the previous activity, you learned that Anna Garcia has abnormally high cholesterol levels. Because of this result, Anna was sent back to the lab for

More information

Author Proof. Genelex Corporation COMPANY PROFILE

Author Proof. Genelex Corporation COMPANY PROFILE COMPANY PROFILE Genelex Corporation Howard Coleman 1,2 & Kristine Ashcraft 1 Author for correspondence 1 Genelex Corporation, 3000 First Ave., Ste. One, Seattle, WA 98121, USA Tel.: +1 800 523 6487; Fax:

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and

More information

Molecular Medicine and Cardiovascular Effects of Drugs

Molecular Medicine and Cardiovascular Effects of Drugs Presented at Biometrical Analysis of Molecular Markers Heidelberg, Germany 22 November 2001 Bernhard R. Winkelmann, MD Monika Seibert-Grafe, MD Walter E. Haefeli, MD Kooperationseinheit Pharmakogenomik/Angewandte

More information

Si mon P t e ersen J ones

Si mon P t e ersen J ones Simon Petersen Jones What is a DNA based Test Uses sample of DNA Blood Cheek Swab Identifies the genotype (not phenotype) of the animal There are Two Categories of Test: Mutation Detection Direct detection

More information

Pharmacogenomics

Pharmacogenomics Pharmacogenomics http://www.pharmgkb.org/ Michelle Whirl-Carrillo, PhD Department of Genetics Pharmacogenetics Defined http://www.pharmgkb.org/ The role of genetics in drug responses. F. Vogel, 1959 CP1077369-1

More information

Guideline on key aspects for the use of pharmacogenomics in the pharmacovigilance of medicinal products

Guideline on key aspects for the use of pharmacogenomics in the pharmacovigilance of medicinal products 24 September 2015 EMA/CHMP/281371/2013 Committee for Medicinal Products for Human Use (CHMP) Guideline on key aspects for the use of pharmacogenomics in the pharmacovigilance of medicinal products Draft

More information

ejifcc: IFCC PROFESSIONAL SCIENTIFIC EXCHANGE PROGRAMME (PSEP) REPORT: CYP1A2 AND CYP3A4 GENE POLYMORPHISMS Paloma Oliver Sáez

ejifcc:   IFCC PROFESSIONAL SCIENTIFIC EXCHANGE PROGRAMME (PSEP) REPORT: CYP1A2 AND CYP3A4 GENE POLYMORPHISMS Paloma Oliver Sáez How to Cite this article: CYP1A2 and CYP3A4 Gene Polymorphisms - 2005 http://www.ifcc.org/ejifcc/vol16no3/ 160309200504.htm IFCC PROFESSIONAL SCIENTIFIC EXCHANGE PROGRAMME (PSEP) REPORT: CYP1A2 AND CYP3A4

More information

Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products 12 December 2011 EMA/CHMP/37646/2009 Committee for Medicinal Products for Human Use (CHMP) Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

More information

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap

More information

The role of genomics in the development of new and improved therapies

The role of genomics in the development of new and improved therapies The role of genomics in the development of new and improved therapies An appreciation of the importance of genetic diversity will have a profound impact on how drugs are discovered, developed and prescribed.

More information

MRC-Holland MLPA. Description version 12; 16 March 2015

MRC-Holland MLPA. Description version 12; 16 March 2015 P128-C1 Cytochrome P450 mix Lot C1-1014. As compared to version B2 (lot B2-0811), nine reference s have been replaced and one CYP2D6 has been removed. This SALSA mix is for basic research and intended

More information

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Trend in diagnostic biochip development Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Handling of the early stage is important for

More information

Pharmacogenomics information in SmPC

Pharmacogenomics information in SmPC Pharmacogenomics information in SmPC SmPC training presentation Note: for full information refer to the European Commission's Guideline on summary of product characteristics (SmPC) SmPC Advisory Group

More information

The Wonderful World of Informatics

The Wonderful World of Informatics The Wonderful World of Informatics VI Jornadas Universitarias de Sistemas de Informción en Salud 31 de octubre, 1 y 2 de noviembre 2011 W. Ed Hammond, PhD, FACMI, FAIMI, FAIMBE, FHL7 Director, Duke Center

More information

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium Cathelijne H. van der Wouden, PharmD PhD Candidate U-PGx Dept. of Clinical Pharmacy

More information

Chapter. Scientific background

Chapter. Scientific background Chapter Scientific background 2 Scientific background Introduction 2.1 This chapter explains how genetic variation can affect response to medicines, and uses case studies to illustrate how information

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Statin-induced Myopathy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_statin-induced_myopathy 6/2013 7/2018 7/2019

More information

Farmacogenomics: meerwaarde en plaats in de Klinische Biologie

Farmacogenomics: meerwaarde en plaats in de Klinische Biologie Farmacogenomics: meerwaarde en plaats in de Klinische Biologie Pieter Vermeersch*, M.D. Ph.D. & Steven Pauwels, Pharm. Laboratory Medicine, UZ Leuven * EFLM / ESPT working group on Personalized Medicine

More information

FDA s Critical Path Initiative and Drug Development

FDA s Critical Path Initiative and Drug Development FDA s Critical Path Initiative and Drug Development Duu-Gong Wu, PhD Executive Director, PharmaNet Consulting The views expressed herein are solely those of the author and do not necessarily reflect the

More information

Part II of IV: Precision Medicine and Pharmacogenomics. How pharmacogenomics is improving patient care

Part II of IV: Precision Medicine and Pharmacogenomics. How pharmacogenomics is improving patient care Part II of IV: Precision Medicine and Pharmacogenomics How pharmacogenomics is improving patient care March 2018 Author Kelly Chillingworth, RPh, MHA/Ed, CGP Senior Pharmacy Consultant Lockton Benefit

More information

Genetic Components of Predicting Drug Adverse Reactions in the Confederated Salish & Kootenai Tribal Population

Genetic Components of Predicting Drug Adverse Reactions in the Confederated Salish & Kootenai Tribal Population Genetic Components of Predicting Drug Adverse Reactions in the Confederated Salish & Kootenai Tribal Population Mark Pershouse PhD University of Montana Department of Biomedical and Pharmaceutical Sciences

More information

Systematic Review into the Role of Genomics in Profiling Overall Drug Performance and Variability

Systematic Review into the Role of Genomics in Profiling Overall Drug Performance and Variability Systematic Review into the Role of Genomics in Profiling Overall Drug Performance and Variability Kaur N and Russell CA* Aston School of Pharmacy, Aston University, Birmingham, UK Research Article Received

More information

Gene therapy. Findings by Alert

Gene therapy. Findings by Alert Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed

More information

Pharmacogenomics in Pain Management

Pharmacogenomics in Pain Management WHITE PAPER Pharmacogenomics in Pain Management Personalized Pain Therapy Authors: ANDREW PURCHASE, BSc Associate Director, Safety & Risk Management PRA Health Sciences LYNN WEBSTER, MD Vice President,

More information

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers FACT SHEET 22 Clinical Trials: Questions and Answers What is a clinical trial? Clinical trials are research studies that answer scientific questions and try to find better ways to prevent, screen for,

More information

Your story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH

Your story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH What s your story? Your story is unique It s a complex intersection of where you ve come from, and where your everyday choices are taking you. Optimal health choices for you might be different from others.

More information

NIH Public Access Author Manuscript Clin Pharmacol Ther. Author manuscript; available in PMC 2013 April 29.

NIH Public Access Author Manuscript Clin Pharmacol Ther. Author manuscript; available in PMC 2013 April 29. NIH Public Access Author Manuscript Published in final edited form as: Clin Pharmacol Ther. 2012 October ; 92(4): 428 430. doi:10.1038/clpt.2012.116. Relevance of missing heritability in pharmacogenomics

More information

Investing in Discovery

Investing in Discovery Investing in Discovery The Impact of Basic Research and the Role of the National Institute of General Medical Sciences Jeremy M. Berg, Ph.D. Director National Institute of General Medical Sciences National

More information

ORDERING HEALTHCARE PROFESSIONAL. Nilesh Dharajiya, M.D Nexus Center Drive San Diego, CA US. Cardiovascular Health

ORDERING HEALTHCARE PROFESSIONAL. Nilesh Dharajiya, M.D Nexus Center Drive San Diego, CA US. Cardiovascular Health Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya, M.D. CARDIAC DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Caucasian ORDERING HEALTHCARE PROESSIONAL Nilesh Dharajiya,

More information

AutoGenomics, Inc. COMPANY PROFILE. For reprint orders, please contact:

AutoGenomics, Inc. COMPANY PROFILE. For reprint orders, please contact: For reprint orders, please contact: reprints@future-medicine.co.uk COMPANY PROFILE AutoGenomics, Inc. Ram Vairavan Vice President, Marketing & Business Development 2270-K, Camino Vida Roble Carlsbad, CA

More information

Student Sheet 1.1: KWL Chart

Student Sheet 1.1: KWL Chart Student s Name Date Class Student Sheet 1.1: KWL Chart Topic: K W L What do you Know? What do you Want to know? What did you Learn? Lesson 1 / Pre-Assessment: Genes and Molecular Machines Student s Name

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Statin-induced Myopathy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_statin-induced_myopathy 6/2013 7/2017 7/2018

More information

impact on a trial design and labeling

impact on a trial design and labeling Genotyping-impact impact on a trial design and labeling Yoshiaki Uyama,, Ph.D. Office of New Drug III (PMDA) Benefit of Pharmacogenomics Improving benefit/risk ratio More safe, more effective Adjusting

More information

6th Form Open Day 15th July 2015

6th Form Open Day 15th July 2015 6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine

More information

Product Description SALSA MLPA probemix P128-D1 CYP450 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P128-D1 CYP450 To be used with the MLPA General Protocol. Product Description SALSA mix P128-D1 CYP450 To be used with the MLPA General Protocol. Version D1. As compared to version C1, one for CYP2B6 and one for CYP3A5 were removed, in addition one reference

More information

Disclosure. Gaps in Knowledge, Competence, Performance, or Patient Outcomes 7/10/2018. Overview. Precision Medicine: Outlive Your Family History

Disclosure. Gaps in Knowledge, Competence, Performance, or Patient Outcomes 7/10/2018. Overview. Precision Medicine: Outlive Your Family History Precision Medicine: Outlive Your Family History Disclosure I have commercial relationships with: Willard H. Dere MD FACP Professor of Internal Medicine June 21, 2018 Shareholder: Amgen, BioMarin, Eli Lilly

More information

CIE Biology A-level Topic 16: Inherited change

CIE Biology A-level Topic 16: Inherited change CIE Biology A-level Topic 16: Inherited change Notes Meiosis is a form of cell division that gives rise to genetic variation. The main role of meiosis is production of haploid gametes as cells produced

More information

Chapter 15 THE HUMAN GENOME PROJECT AND GENOMICS

Chapter 15 THE HUMAN GENOME PROJECT AND GENOMICS Chapter 15 THE HUMAN GENOME PROJECT AND GENOMICS Chapter Summary Mapping of human genes means identifying the chromosome and the position on that chromosome where a particular gene is located. Initially

More information

Integrating Genomics in Family Medicine

Integrating Genomics in Family Medicine Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Integrating Genomics in Family Medicine Brian Stello MD Lehigh Valley Health Network, Brian.Stello@lvhn.org Follow this and

More information

Guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products

Guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products 1 2 3 10 January 2014 EMA/281371/2013 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation

More information

January 11, Genetics with DNA.notebook. Genetics

January 11, Genetics with DNA.notebook. Genetics Genetics 1.DNA (deoxyribonucleic acid) is a chemical code that contains information for an organisms growth and function. It is found in the nucleus of all cells. 2. A gene is a section of DNA on a chromosome.the

More information

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT GBinsight Sample Name: GB4408 Race: East Asian Gender: Female Reason for Testing: Family history of premature CAD MRN: 0123456790 Specimen: Saliva Received: 07/26/2016 Test ID: 113-1487118782-1 Test: Dyslipidemia

More information

New Paradigms for Advancing Personalized Medicine

New Paradigms for Advancing Personalized Medicine 1 2 New Paradigms for Advancing Personalized Medicine 1 Panelists Moderated by: Antoinette Konski, Partner, Foley & Lardner LLP Speakers: Anita Chawla, Ph.D., Vice President, Analysis Group Ken Goldman,

More information

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you

More information

TOWARDS INDIVIDUALIZED MEDICINE: INSIGHTS GAINED FROM GENOMIC STUDIES

TOWARDS INDIVIDUALIZED MEDICINE: INSIGHTS GAINED FROM GENOMIC STUDIES & TOWARDS INDIVIDUALIZED MEDICINE: INSIGHTS GAINED FROM GENOMIC STUDIES Salman Kirmani*, Dusica Babovic-Vuksanovic Department of Medical Genetics, Mayo Clinic College of Medicine, 200 First Street SW,

More information

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome. Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all

More information

Biology 321 Start Reading Chapter 6 in text. Also look carefully again at: 10 th edition pg on polymorphisms

Biology 321 Start Reading Chapter 6 in text. Also look carefully again at: 10 th edition pg on polymorphisms Biology 321 Start Reading Chapter 6 in text Also look carefully again at: 10 th edition pg 58-60 on polymorphisms NOTE: In this and subsequent lectures, we may or may not review and/or discuss every example

More information

A A T A C G T G A G T G A G G C C T T A A

A A T A C G T G A G T G A G G C C T T A A Living in a Genomic World: Unraveling the Complexity of GWAS Studies by Rivka L. Glaser, Department of Biology, Stevenson University, Stevenson, MD Erin L. Zimmer, Department of Biology, Lewis University,

More information

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof 2 Lina Al-Lawama Rama Al-Ashqar Malik Al-Zohlof Anticoagulant drugs Recap Last lecture we were talking about antiplatelet drugs, we mentioned 5 drugs : Aspirin which is used alone with patents that have

More information

of heritable factor ). 1. The alternative versions of genes are called alleles. Chapter 9 Patterns of Inheritance

of heritable factor ). 1. The alternative versions of genes are called alleles. Chapter 9 Patterns of Inheritance Chapter 9 Biology and Society: Our Longest-Running Genetic Experiment: Dogs Patterns of Inheritance People have selected and mated dogs with preferred traits for more than 15,000 years. Over thousands

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_statin_induced_myopathy 01/01/2019 N/A 01/01/2020 01/01/2019 Description of Procedure

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

AS91159 Demonstrate understanding of gene expression

AS91159 Demonstrate understanding of gene expression AS91159 Demonstrate understanding of gene expression Mutations and Metabolic Pathways (2015,2) In 1941 biologists George Beadle and Edward Tatum exposed the bread mould Neurospora crassa to radiation.

More information

So, just exactly when will genetics revolutionise medicine? - Part 1

So, just exactly when will genetics revolutionise medicine? - Part 1 So, just exactly when will genetics revolutionise medicine? - Part 1 PRO F. M A RT IN K E N N E DY D EPA RT M ENT O F PAT H O LO GY & C A R N E Y C E N T R E FO R PH A R M ACO GEN O M IC S U N IVERSIT

More information

The Beery Twins Story and Sepiapterin Reductase

The Beery Twins Story and Sepiapterin Reductase The Beery Twins Story and Sepiapterin Reductase Sepiapterin reductase (SPR) is an enzyme that makes tetrahydrobiopterin an important cofactor used by other enzymes to make the neurotransmitters dopamine

More information

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory

More information

Genetically Sequencing Healthy Babies Yielded Surprising Results

Genetically Sequencing Healthy Babies Yielded Surprising Results Genetically Sequencing Healthy Babies Yielded Surprising Results FUTURE FRONTIERS OPINION ESSAY Robert C. Green, MD, MPH January 22, 2019 8 MINUTE READ A newborn and mother in the hospital - first touch.

More information

Introduc)on to Pharmacology and Pharmacogenomics. Roxana Daneshjou May 9, 2013

Introduc)on to Pharmacology and Pharmacogenomics. Roxana Daneshjou May 9, 2013 Introduc)on to Pharmacology and Pharmacogenomics Roxana Daneshjou May 9, 2013 Pharmacogenomics Pharma = Drug Genomics/Gene)cs = study of gene)c informa)on Pharmacogenomics = study of how gene)cs/ genomics

More information

Icd code 10 use of low molecular weight heparin

Icd code 10 use of low molecular weight heparin Icd code 10 use of low molecular weight heparin The Borg System is 100 % Icd code 10 use of low molecular weight heparin ICD -10 is a diagnostic coding system implemented by the World Health Organization.

More information

General background text Pharmacogenetics Dihydropyrimidine dehydrogenase (DPD)

General background text Pharmacogenetics Dihydropyrimidine dehydrogenase (DPD) General background text Pharmacogenetics Dihydropyrimidine dehydrogenase (DPD) Last updated: 26 October 2017 Definitions in pharmacogenetics The genotype is the hereditary information about a specific

More information

A / adenine and T / thymine and C / cytosine and G / guanine do not allow U / uracil 1

A / adenine and T / thymine and C / cytosine and G / guanine do not allow U / uracil 1 M.(a) phosphate allow PO 4 3 do not allow P (b) A / adenine and T / thymine and C / cytosine and G / guanine do not allow U / uracil (c) (mutation) changes from C to T DNA code or there is a change in

More information

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work. Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Kimmel SE, French B, Kasner SE, et al. A pharmacogenetic versus a clinical

More information

iccnet CHSA Clinical Protocol - HEPARIN

iccnet CHSA Clinical Protocol - HEPARIN Name: iccnet CHSA Clinical Protocol - HEPARIN This clinical guideline or clinical protocol is based on a review of best practice evidence and expert opinion. It is intended to guide practice and does not

More information

Discrete vs continuous trait eye color and skin color in humans shows continuous variation as does fruit size in tomato culivars

Discrete vs continuous trait eye color and skin color in humans shows continuous variation as does fruit size in tomato culivars Biology 321 Start Reading Chapter 6 in text (both editions) Also look carefully again at: 10 th edition pg 58-60 on polymorphism 9 th edition 69-71 on polymorphism NOTE: In this and subsequent lectures,

More information

What is Genetics? Genetics The study of how heredity information is passed from parents to offspring. The Modern Theory of Evolution =

What is Genetics? Genetics The study of how heredity information is passed from parents to offspring. The Modern Theory of Evolution = What is Genetics? Genetics The study of how heredity information is passed from parents to offspring The Modern Theory of Evolution = Genetics + Darwin s Theory of Natural Selection Gregor Mendel Father

More information

Moving Medication to Market More Quickly

Moving Medication to Market More Quickly Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/moving-medication-to-market-more-quickly/1981/

More information

Pharmacogenomics Relating to Drug Evaluation

Pharmacogenomics Relating to Drug Evaluation Pharmacogenomics Relating to Drug Evaluation Yoshiaki Uyama,, Ph.D. Office of New Drug III (PMDA) Recent Topics relating to PGx Tarceva (erlotinib) Approved by FDA in Nov 2004 for NSCLC Randomized, Double-Blind,

More information

Single Nucleotide Variant Analysis. H3ABioNet May 14, 2014

Single Nucleotide Variant Analysis. H3ABioNet May 14, 2014 Single Nucleotide Variant Analysis H3ABioNet May 14, 2014 Outline What are SNPs and SNVs? How do we identify them? How do we call them? SAMTools GATK VCF File Format Let s call variants! Single Nucleotide

More information

David C. Whitcomb, MD, PhD and Philip E. Empey, PharmD, PhD

David C. Whitcomb, MD, PhD and Philip E. Empey, PharmD, PhD David C. Whitcomb, MD, PhD and Philip E. Empey, PharmD, PhD Part 1 MODERN MEDICINE - FOCUSED ON GERMS Germ Theory of Disease The germ theory of disease states that some diseases are caused by microorganisms.

More information

Explain why the scientists used the same restriction endonuclease enzymes on each DNA sample

Explain why the scientists used the same restriction endonuclease enzymes on each DNA sample Q1.Some populations of flies are becoming resistant to insecticides intended to kill them. Scientists developed a method for finding out whether a fly was carrying a recessive allele, r, that gives resistance

More information

Happy Monday! Have out: 15.1 Notes (due today) Pen or pencil. Upcoming: 15.1 Quiz on block day 15.2 Notes due Friday (2/1)

Happy Monday! Have out: 15.1 Notes (due today) Pen or pencil. Upcoming: 15.1 Quiz on block day 15.2 Notes due Friday (2/1) Happy Monday! Have out: 15.1 Notes (due today) Pen or pencil Upcoming: 15.1 Quiz on block day 15.2 Notes due Friday (2/1) Plan for today Check 15.1 Notes Go over 15.1 Practice problems 15.1: Human Chromosomes

More information

Pharmacogenetics VALIDATION OF GENE VARIANT TESTING IN PHARMACOGENETICS WITH SEQUENOM MASSARRAY AND PCR

Pharmacogenetics VALIDATION OF GENE VARIANT TESTING IN PHARMACOGENETICS WITH SEQUENOM MASSARRAY AND PCR Pharmacogenetics VALIDATION OF GENE VARIANT TESTING IN PHARMACOGENETICS WITH SEQUENOM MASSARRAY AND PCR Prathima Misrielal Research Project July 15, 2015 Department of Genetics Supervisors: Prof. Dr. R.H.

More information

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde Managing the Risks Associated with Anticoagulant Therapy Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde Background Identified as high risk medicines Wide range

More information

Biomarkers and clinical trials. Patricia woo UCL

Biomarkers and clinical trials. Patricia woo UCL Biomarkers and clinical trials Patricia woo UCL Definitions Surrogate biomarker: A laboratory or physical sign that is used in therapeutic trials as a substitute for a clinically meaningful endpoint, e.g.

More information

Pharmacogenetics in American Indian Populations

Pharmacogenetics in American Indian Populations Pharmacogenetics in American Indian Populations Erica L. Woodahl, Ph.D. Associate Professor Department of Biomedical and Pharmaceutical Sciences University of Montana What is Pharmacogenomics? Responders

More information

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2 News Release Bayer HealthCare AG Corporate Communications 51368 Leverkusen Germany Phone +49 214 30 1 www.news.bayer.com Venous Blood Clot Prevention after Hip Replacement Surgery: The Lancet Publishes

More information

CTS. Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges. Clinical and Translational Science

CTS. Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges. Clinical and Translational Science CTS Citation: Clin Transl Sci (2016) 9, 233 245; C 2016 ASCPT. All rights reserved doi:10.1111/cts.12404 TUTORIAL Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation

More information

Personalized Medicine: What does it mean and why do we want to get there?

Personalized Medicine: What does it mean and why do we want to get there? Personalized Medicine: What does it mean and why do we want to get there? Dan M. Roden MD Assistant Vice Chancellor for Personalized Medicine Principal Investigator, BioVU Vanderbilt University Medical

More information

The ABC s of Pharmacogenomics and Pharmacogenetics. Guillaume Pare MD, M.Sc., FRCPc Research Fellow Harvard Medical School

The ABC s of Pharmacogenomics and Pharmacogenetics. Guillaume Pare MD, M.Sc., FRCPc Research Fellow Harvard Medical School The ABC s of Pharmacogenomics and Pharmacogenetics Guillaume Pare MD, M.Sc., FRCPc Research Fellow Harvard Medical School Objectives Understand terms relating to pharmacogenomics and pharmacogenetics Understand

More information

About Clinical Trials: What They Can Mean For You?

About Clinical Trials: What They Can Mean For You? About Clinical Trials: What They Can Mean For You? Karl Cremer, PharmD and AnnKatrin Petersen, MD, MS January 25, 2012 ClinicalStudy.org Owned and operated by PRI, Inc. 5927 Balfour Court, Suite 201 Carlsbad,

More information

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs

More information

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome

More information

Nanthealth Patient Informed Consent

Nanthealth Patient Informed Consent Patient Informed Consent Why am I being asked to give consent? You are being asked to sign this consent form because you want to have a molecular/genomic analysis performed to help your physician understand

More information